Outcomes of surveillance in patients with intraductal papillary mucinous neoplasms (IPMNs) who tested negative for high-risk mutations (HRMs) in next-generation sequencing (NGS).
Authors
Veronica Coleman
Gilbert Z. Murimwa (ORCID: https://orcid.org/0000-0001-7948-0980)
Outcomes of surveillance in patients with intraductal papillary mucinous neoplasms (IPMNs) who tested negative for high-risk mutations (HRMs) in next-generation sequencing (NGS).
Veronica Coleman, Gilbert Z. Murimwa, Patricio Marcelo Polanco, Jason B. Fleming et al.
Journal
Journal of Clinical Oncology
Topics
Medical Imaging and Pathology Studies
article
Outcomes of surveillance in patients with intraductal papillary mucinous neoplasms (IPMNs) who tested negative for high-risk mutations (HRMs) in next-generation sequencing (NGS).
Veronica Coleman, Gilbert Z. Murimwa, Patricio Marcelo Polanco, Jason B. Fleming, Samantha B. Foley, Tarek Sawas, Gaurav Khatri, Naveen Rajamohan, Daniel J. Ellis, Hendrikus Dutch Vanderveldt, Herbert J. Zeh, Nisa Kubiliun, Amudhan Kannan, John C. Mansour
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 43(4_suppl)
Institutions
The University of Texas Southwestern Medical Center (US)